Shares of US Treasury 3 Month Bill ETF (NASDAQ:TBIL – Get Free Report) hit a new 52-week low during mid-day trading on Tuesday. The company traded as low as $49.82 and last traded at $49.8250, with a volume of 180,857 shares changing hands. The stock had previously closed at $49.99.
US Treasury 3 Month Bill ETF Trading Down 0.3%
The business’s fifty day simple moving average is $49.92 and its 200 day simple moving average is $49.92.
Institutional Investors Weigh In On US Treasury 3 Month Bill ETF
A number of institutional investors have recently made changes to their positions in TBIL. Compass Financial Management LLC acquired a new position in US Treasury 3 Month Bill ETF in the second quarter valued at about $25,000. Sound Income Strategies LLC acquired a new position in shares of US Treasury 3 Month Bill ETF during the 1st quarter worth about $116,000. Center for Financial Planning Inc. bought a new stake in shares of US Treasury 3 Month Bill ETF in the 3rd quarter valued at about $198,000. Roxbury Financial LLC raised its position in shares of US Treasury 3 Month Bill ETF by 33.5% in the 2nd quarter. Roxbury Financial LLC now owns 7,030 shares of the company’s stock valued at $351,000 after acquiring an additional 1,763 shares during the period. Finally, HORAN Wealth LLC acquired a new stake in shares of US Treasury 3 Month Bill ETF in the 2nd quarter valued at approximately $479,000.
US Treasury 3 Month Bill ETF Company Profile
The US Treasury 3 Month Bill ETF (TBIL) is an exchange-traded fund that is based on the ICE BofA US Treasury Bill 3 Month index. The fund is a passively managed, single-bond fund that invests in the most recently issued, on-the-run, 3-month US Treasury Bill. The fund is designed for those specifically required to track the 3-month tenor on the yield curve. TBIL was launched on Aug 9, 2022 and is managed by F/m Investments.
See Also
- Five stocks we like better than US Treasury 3 Month Bill ETF
- Approaching Earnings Season, Are Pure Play Quantum Stocks Still a Good Bet?
- Lockheed Martin’s F-35 Deal Could Change How Wall Street Values the Stock
- Merck and Moderna’s Cancer Vaccine Worked—Who Gets Paid?
- Intel’s $155 Price Target Raises a Bigger Question About Its Turnaround Potential
Receive News & Ratings for US Treasury 3 Month Bill ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for US Treasury 3 Month Bill ETF and related companies with MarketBeat.com's FREE daily email newsletter.
